English

IMMUNEX CORP /DE/

EDGAR

Quarterly report (10-Q) · filed 2002-05-09

31 filing records in this dataset, filed from 1995-03-20 to 2002-05-09. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

272 million USD

2002-03-31 · USD

Exact inputs and evidence

Revenue: 271963000 USD Source

Operating margin

9.97%

2002-03-31 · %

Exact inputs and evidence

Operating Income: 27125000 USD Source
Revenue: 271963000 USD Source

Operating cash flow

3.31 million USD

2002-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: 3313000 USD Source

Free cash flow

-367 million USD

2002-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: 3313000 USD Source
Capital Expenditure: 370654000 USD Source

Cash and cash equivalents: 85.9 million USD 2002-03-31 Source
Exact value

85931000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

1.04 billion USD

2001-04-01 – 2002-03-31

Exact inputs and evidence

Revenue: 238289000 USD · 2001-04-01 – 2001-06-30 Source
Revenue: 252963000 USD · 2001-07-01 – 2001-09-30 Source
Revenue: 986805000 USD · 2001-01-01 – 2001-12-31 Source
Revenue: 709091000 USD · 2001-01-01 – 2001-09-30 Source
Revenue: 271963000 USD · 2002-01-01 – 2002-03-31 Source

Net income

165 million USD

2001-04-01 – 2002-03-31

Exact inputs and evidence

Net income: 48817000 USD · 2001-04-01 – 2001-06-30 Source
Net income: 39687000 USD · 2001-07-01 – 2001-09-30 Source
Net income: 169963000 USD · 2001-01-01 – 2001-12-31 Source
Net income: 128337000 USD · 2001-01-01 – 2001-09-30 Source
Net income: 34927000 USD · 2002-01-01 – 2002-03-31 Source

Capital expenditure

421 million USD

2001-04-01 – 2002-03-31

Exact inputs and evidence

Capital expenditure: 30675000 USD · 2001-01-01 – 2001-06-30 Source
Capital expenditure: 14903000 USD · 2001-01-01 – 2001-03-31 Source
Capital expenditure: 44176000 USD · 2001-01-01 – 2001-09-30 Source
Capital expenditure: 30675000 USD · 2001-01-01 – 2001-06-30 Source
Capital expenditure: 65011000 USD · 2001-01-01 – 2001-12-31 Source
Capital expenditure: 44176000 USD · 2001-01-01 – 2001-09-30 Source
Capital expenditure: 370654000 USD · 2002-01-01 – 2002-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2002-05-09.

Financial data available through: 2001-12-31.

Coverage by financial measure

Revenue: 10 of 11 periods available· newest 2001-12-31
Operating income: 10 of 11 periods available· newest 2001-12-31
Net income: 10 of 11 periods available· newest 2001-12-31
Operating cash flow: 10 of 11 periods available· newest 2001-12-31
Capital expenditure: 10 of 11 periods available· newest 2001-12-31
Total assets: 9 of 11 periods available· newest 2001-12-31
liabilities: No compatible figures in this window
Current assets: 8 of 11 periods available· newest 2001-12-31
Current liabilities: 8 of 11 periods available· newest 2001-12-31
Cash and cash equivalents: 10 of 11 periods available· newest 2001-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+14.5%

Prior period

USD 861.83 million

2000-01-01 – 2000-12-31
Current period

USD 986.81 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

986805000 − 861829000 = 124976000 USD

861829000 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
986805000 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · IMMUNEX CORP /DE/ · 2001-12-31 IMMUNEX CORP /DE/ (edgar:719529) Year-over-year change in Revenue: 124976000 USD Concept: fundies:Revenue Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 986805000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001032210-02-000357.txt#4261 Input fundies:Revenue: 861829000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001032210-02-000357.txt#4261
The citation records this snapshot. The page link may show a newer release later.
Net income
+10.1%

Prior period

USD 154.35 million

2000-01-01 – 2000-12-31
Current period

USD 169.96 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

169963000 − 154352000 = 15611000 USD

154352000 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
169963000 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · IMMUNEX CORP /DE/ · 2001-12-31 IMMUNEX CORP /DE/ (edgar:719529) Year-over-year change in Net income: 15611000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 169963000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001032210-02-000357.txt#4374 Input fundies:NetIncome: 154352000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001032210-02-000357.txt#4374
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+30.5%

Prior period

USD 171.88 million

2000-01-01 – 2000-12-31
Current period

USD 224.29 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

224285000 − 171880000 = 52405000 USD

171880000 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
224285000 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · IMMUNEX CORP /DE/ · 2001-12-31 IMMUNEX CORP /DE/ (edgar:719529) Year-over-year change in Operating cash flow: 52405000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 224285000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001032210-02-000357.txt#4388 Input fundies:OperatingCashFlow: 171880000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001032210-02-000357.txt#4388
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-19.4%

Prior period

USD 80.68 million

2000-01-01 – 2000-12-31
Current period

USD 65.01 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

65011000 − 80675000 = -15664000 USD

80675000 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
65011000 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · IMMUNEX CORP /DE/ · 2001-12-31 IMMUNEX CORP /DE/ (edgar:719529) Year-over-year change in Capital expenditure: -15664000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 65011000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001032210-02-000357.txt#4392 Input fundies:CapitalExpenditure: 80675000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001032210-02-000357.txt#4392
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2001 2001-01-01 – 2001-12-31

Revenue USD 986.81 million 100% of revenue
Operating costs Derived USD 889.39 million 90% of revenue
Operating income USD 97.42 million 9.9% of revenue
Tax, interest and other Derived −USD 72.55 million −7.4% of revenue
Net income USD 169.96 million 17% of revenue

Cash

Operating cash flow USD 224.29 million 23% of revenue
Capital expenditure USD 65.01 million 6.6% of revenue
Free cash flow Derived USD 159.27 million 16% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1992 Operating loss: operating costs were 246% of revenue.
1993 Operating loss: operating costs were 483% of revenue.
1994 Operating loss: operating costs were 120% of revenue.
1995 Operating loss: operating costs were 107% of revenue.
1996 Operating loss: operating costs were 125% of revenue.
1997 Operating loss: operating costs were 111% of revenue.
1998 Operating loss: operating costs were 101% of revenue.
1999 Net income was higher than operating income, so the split is not drawn.
2000 Net income was higher than operating income, so the split is not drawn.
2001 Net income was higher than operating income, so the split is not drawn.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1992 1992-01-01 – 1992-12-31	60082000	147926000 Derived	-87844000	-10247000 Derived	-77597000	-33556000 Derived	Source 1992-01-01 – 1992-12-31: 60082000 USD Inspect Revenue Open source 1992-01-01 – 1992-12-31: -87844000 USD Inspect Operating Income Open source 1992-01-01 – 1992-12-31: -77597000 USD Inspect Net Income Open source 1992-01-01 – 1992-12-31: -3620000 USD Inspect Operating Cash Flow Open source 1992-01-01 – 1992-12-31: 29936000 USD Inspect Capital Expenditure Open source
1993 1993-01-01 – 1993-12-31	95310000	460761000 Derived	-365451000	684000 Derived	-366135000	-37390000 Derived	Source 1993-01-01 – 1993-12-31: 95310000 USD Inspect Revenue Open source 1993-01-01 – 1993-12-31: -365451000 USD Inspect Operating Income Open source 1993-01-01 – 1993-12-31: -366135000 USD Inspect Net Income Open source 1993-01-01 – 1993-12-31: -31271000 USD Inspect Operating Cash Flow Open source 1993-01-01 – 1993-12-31: 6119000 USD Inspect Capital Expenditure Open source
1994 1994-01-01 – 1994-12-31	144332000	173462000 Derived	-29130000	3974000 Derived	-33104000	-23526000 Derived	Source 1994-01-01 – 1994-12-31: 144332000 USD Inspect Revenue Open source 1994-01-01 – 1994-12-31: -29130000 USD Inspect Operating Income Open source 1994-01-01 – 1994-12-31: -33104000 USD Inspect Net Income Open source 1994-01-01 – 1994-12-31: -15735000 USD Inspect Operating Cash Flow Open source 1994-01-01 – 1994-12-31: 7791000 USD Inspect Capital Expenditure Open source
1995 1995-01-01 – 1995-12-31	156616000	167336000 Derived	-10720000	580000 Derived	-11300000	6152000 Derived	Source 1995-01-01 – 1995-12-31: 156616000 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: -10720000 USD Inspect Operating Income Open source 1995-01-01 – 1995-12-31: -11300000 USD Inspect Net Income Open source 1995-01-01 – 1995-12-31: 11398000 USD Inspect Operating Cash Flow Open source 1995-01-01 – 1995-12-31: 5246000 USD Inspect Capital Expenditure Open source
1996 1996-01-01 – 1996-12-31	151198000	188440000 Derived	-37242000	16390000 Derived	-53632000	-47705000 Derived	Source 1996-01-01 – 1996-12-31: 151198000 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -37242000 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: -53632000 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -43049000 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 4656000 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	185297000	205139000 Derived	-19842000	-4070000 Derived	-15772000	7654000 Derived	Source 1997-01-01 – 1997-12-31: 185297000 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -19842000 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: -15772000 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: 15063000 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 7409000 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	243450000	247016000 Derived	-3566000	-4552000 Derived	986000	-6161000 Derived	Source 1998-01-01 – 1998-12-31: 243450000 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -3566000 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: 986000 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: 23228000 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 29389000 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	541718000	502665000 Derived	39053000	-5271000 Derived	44324000	77169000 Derived	Source 1999-01-01 – 1999-12-31: 541718000 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: 39053000 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: 44324000 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: 112732000 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 35563000 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	861829000	754239000 Derived	107590000	-46762000 Derived	154352000	91205000 Derived	Source 2000-01-01 – 2000-12-31: 861829000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: 107590000 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: 154352000 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: 171880000 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 80675000 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	986805000	889390000 Derived	97415000	-72548000 Derived	169963000	159274000 Derived	Source 2001-01-01 – 2001-12-31: 986805000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: 97415000 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: 169963000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: 224285000 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 65011000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 986.8M 2001

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19921992-12-31	Revenue	60082000	Revenue: 60082000 Open source
19931993-12-31	Revenue	95310000	Revenue: 95310000 Open source
19941994-12-31	Revenue	144332000	Revenue: 144332000 Open source
19951995-12-31	Revenue	156616000	Revenue: 156616000 Open source
19961996-12-31	Revenue	151198000	Revenue: 151198000 Open source
19971997-12-31	Revenue	185297000	Revenue: 185297000 Open source
19981998-12-31	Revenue	243450000	Revenue: 243450000 Open source
19991999-12-31	Revenue	541718000	Revenue: 541718000 Open source
20002000-12-31	Revenue	861829000	Revenue: 861829000 Open source
20012001-12-31	Revenue	986805000	Revenue: 986805000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

14.5% 2001

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19921992-12-31	Year over year	No prior comparable period	Revenue: 60082000 Open source
19931993-12-31	Year over year	58.6%	Revenue: 95310000 Open source Revenue: 60082000 Open source
19941994-12-31	Year over year	51.4%	Revenue: 144332000 Open source Revenue: 95310000 Open source
19951995-12-31	Year over year	8.5%	Revenue: 156616000 Open source Revenue: 144332000 Open source
19961996-12-31	Year over year	-3.5%	Revenue: 151198000 Open source Revenue: 156616000 Open source
19971997-12-31	Year over year	22.6%	Revenue: 185297000 Open source Revenue: 151198000 Open source
19981998-12-31	Year over year	31.4%	Revenue: 243450000 Open source Revenue: 185297000 Open source
19991999-12-31	Year over year	122.5%	Revenue: 541718000 Open source Revenue: 243450000 Open source
20002000-12-31	Year over year	59.1%	Revenue: 861829000 Open source Revenue: 541718000 Open source
20012001-12-31	Year over year	14.5%	Revenue: 986805000 Open source Revenue: 861829000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 9.9% 2001

Net margin 17.2% 2001

Free cash flow margin 16.1% 2001

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19921992-12-31	Operating margin	-146.2%	Operating Income: -87844000 Open source Revenue: 60082000 Open source
19931993-12-31	Operating margin	-383.4%	Operating Income: -365451000 Open source Revenue: 95310000 Open source
19941994-12-31	Operating margin	-20.2%	Operating Income: -29130000 Open source Revenue: 144332000 Open source
19951995-12-31	Operating margin	-6.8%	Operating Income: -10720000 Open source Revenue: 156616000 Open source
19961996-12-31	Operating margin	-24.6%	Operating Income: -37242000 Open source Revenue: 151198000 Open source
19971997-12-31	Operating margin	-10.7%	Operating Income: -19842000 Open source Revenue: 185297000 Open source
19981998-12-31	Operating margin	-1.5%	Operating Income: -3566000 Open source Revenue: 243450000 Open source
19991999-12-31	Operating margin	7.2%	Operating Income: 39053000 Open source Revenue: 541718000 Open source
20002000-12-31	Operating margin	12.5%	Operating Income: 107590000 Open source Revenue: 861829000 Open source
20012001-12-31	Operating margin	9.9%	Operating Income: 97415000 Open source Revenue: 986805000 Open source
19921992-12-31	Net margin	-129.2%	Net Income: -77597000 Open source Revenue: 60082000 Open source
19931993-12-31	Net margin	-384.2%	Net Income: -366135000 Open source Revenue: 95310000 Open source
19941994-12-31	Net margin	-22.9%	Net Income: -33104000 Open source Revenue: 144332000 Open source
19951995-12-31	Net margin	-7.2%	Net Income: -11300000 Open source Revenue: 156616000 Open source
19961996-12-31	Net margin	-35.5%	Net Income: -53632000 Open source Revenue: 151198000 Open source
19971997-12-31	Net margin	-8.5%	Net Income: -15772000 Open source Revenue: 185297000 Open source
19981998-12-31	Net margin	0.4%	Net Income: 986000 Open source Revenue: 243450000 Open source
19991999-12-31	Net margin	8.2%	Net Income: 44324000 Open source Revenue: 541718000 Open source
20002000-12-31	Net margin	17.9%	Net Income: 154352000 Open source Revenue: 861829000 Open source
20012001-12-31	Net margin	17.2%	Net Income: 169963000 Open source Revenue: 986805000 Open source
19921992-12-31	Free cash flow margin	-55.9%	Revenue: 60082000 Open source Operating Cash Flow: -3620000 Open source Capital Expenditure: 29936000 Open source
19931993-12-31	Free cash flow margin	-39.2%	Revenue: 95310000 Open source Operating Cash Flow: -31271000 Open source Capital Expenditure: 6119000 Open source
19941994-12-31	Free cash flow margin	-16.3%	Revenue: 144332000 Open source Operating Cash Flow: -15735000 Open source Capital Expenditure: 7791000 Open source
19951995-12-31	Free cash flow margin	3.9%	Revenue: 156616000 Open source Operating Cash Flow: 11398000 Open source Capital Expenditure: 5246000 Open source
19961996-12-31	Free cash flow margin	-31.6%	Revenue: 151198000 Open source Operating Cash Flow: -43049000 Open source Capital Expenditure: 4656000 Open source
19971997-12-31	Free cash flow margin	4.1%	Revenue: 185297000 Open source Operating Cash Flow: 15063000 Open source Capital Expenditure: 7409000 Open source
19981998-12-31	Free cash flow margin	-2.5%	Revenue: 243450000 Open source Operating Cash Flow: 23228000 Open source Capital Expenditure: 29389000 Open source
19991999-12-31	Free cash flow margin	14.2%	Revenue: 541718000 Open source Operating Cash Flow: 112732000 Open source Capital Expenditure: 35563000 Open source
20002000-12-31	Free cash flow margin	10.6%	Revenue: 861829000 Open source Operating Cash Flow: 171880000 Open source Capital Expenditure: 80675000 Open source
20012001-12-31	Free cash flow margin	16.1%	Revenue: 986805000 Open source Operating Cash Flow: 224285000 Open source Capital Expenditure: 65011000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 224.3M 2001

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19921992-12-31	Operating cash flow	-3620000	Operating Cash Flow: -3620000 Open source
19931993-12-31	Operating cash flow	-31271000	Operating Cash Flow: -31271000 Open source
19941994-12-31	Operating cash flow	-15735000	Operating Cash Flow: -15735000 Open source
19951995-12-31	Operating cash flow	11398000	Operating Cash Flow: 11398000 Open source
19961996-12-31	Operating cash flow	-43049000	Operating Cash Flow: -43049000 Open source
19971997-12-31	Operating cash flow	15063000	Operating Cash Flow: 15063000 Open source
19981998-12-31	Operating cash flow	23228000	Operating Cash Flow: 23228000 Open source
19991999-12-31	Operating cash flow	112732000	Operating Cash Flow: 112732000 Open source
20002000-12-31	Operating cash flow	171880000	Operating Cash Flow: 171880000 Open source
20012001-12-31	Operating cash flow	224285000	Operating Cash Flow: 224285000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 159.3M 2001

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19921992-12-31	Free cash flow	-33556000	Operating Cash Flow: -3620000 Open source Capital Expenditure: 29936000 Open source
19931993-12-31	Free cash flow	-37390000	Operating Cash Flow: -31271000 Open source Capital Expenditure: 6119000 Open source
19941994-12-31	Free cash flow	-23526000	Operating Cash Flow: -15735000 Open source Capital Expenditure: 7791000 Open source
19951995-12-31	Free cash flow	6152000	Operating Cash Flow: 11398000 Open source Capital Expenditure: 5246000 Open source
19961996-12-31	Free cash flow	-47705000	Operating Cash Flow: -43049000 Open source Capital Expenditure: 4656000 Open source
19971997-12-31	Free cash flow	7654000	Operating Cash Flow: 15063000 Open source Capital Expenditure: 7409000 Open source
19981998-12-31	Free cash flow	-6161000	Operating Cash Flow: 23228000 Open source Capital Expenditure: 29389000 Open source
19991999-12-31	Free cash flow	77169000	Operating Cash Flow: 112732000 Open source Capital Expenditure: 35563000 Open source
20002000-12-31	Free cash flow	91205000	Operating Cash Flow: 171880000 Open source Capital Expenditure: 80675000 Open source
20012001-12-31	Free cash flow	159274000	Operating Cash Flow: 224285000 Open source Capital Expenditure: 65011000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1992-12-31	Liabilities / assets	Not reported	No source recorded
1993-12-31	Liabilities / assets	Not reported	Total Assets: 204118000 Open source
1994-12-31	Liabilities / assets	Not reported	Total Assets: 192665000 Open source
1995-12-31	Liabilities / assets	Not reported	Total Assets: 174037000 Open source
1996-12-31	Liabilities / assets	Not reported	Total Assets: 177787000 Open source
1997-12-31	Liabilities / assets	Not reported	Total Assets: 227333000 Open source
1998-12-31	Liabilities / assets	Not reported	Total Assets: 325325000 Open source
1999-12-31	Liabilities / assets	Not reported	Total Assets: 941241000 Open source
2000-12-31	Liabilities / assets	Not reported	Total Assets: 2039373000 Open source
2001-12-31	Liabilities / assets	Not reported	Total Assets: 2295308000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

4.49× 2001

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1992-12-31	Current assets / current liabilities	Not reported	No source recorded
1993-12-31	Current assets / current liabilities	Not reported	No source recorded
19941994-12-31	Current assets / current liabilities	1.37×	Current Assets: 57339000 Open source Current Liabilities: 41722000 Open source
19951995-12-31	Current assets / current liabilities	1.54×	Current Assets: 50415000 Open source Current Liabilities: 32785000 Open source
19961996-12-31	Current assets / current liabilities	1.73×	Current Assets: 54611000 Open source Current Liabilities: 31497000 Open source
19971997-12-31	Current assets / current liabilities	2.56×	Current Assets: 116593000 Open source Current Liabilities: 45544000 Open source
19981998-12-31	Current assets / current liabilities	2.67×	Current Assets: 201985000 Open source Current Liabilities: 75513000 Open source
19991999-12-31	Current assets / current liabilities	5.86×	Current Assets: 791181000 Open source Current Liabilities: 135085000 Open source
20002000-12-31	Current assets / current liabilities	8.76×	Current Assets: 1756281000 Open source Current Liabilities: 200441000 Open source
20012001-12-31	Current assets / current liabilities	4.49×	Current Assets: 1037221000 Open source Current Liabilities: 230864000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1992 1992-01-01 – 1992-12-31	−USD 77.6 million Exact value Exact value: -77597000 USD 1992-01-01 – 1992-12-31: -77597000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IMMUNEX CORP /DE/ · 1992-12-31 IMMUNEX CORP /DE/ (edgar:719529) Net Income: -77597000 USD Concept: fundies:NetIncome Period: 1992-01-01 to 1992-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529/explain?concept=fundies%3ANetIncome&period=1992-12-31&surface=latest&period_type=duration&start=1992-01-01&unit=USD&dimensions= Input fundies:NetIncome: -77597000 USD (1992-01-01 to 1992-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0000912057-95-001512.txt#2144 The citation records this snapshot. The page link may show a newer release later.	−USD 3.62 million Exact value Exact value: -3620000 USD 1992-01-01 – 1992-12-31: -3620000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IMMUNEX CORP /DE/ · 1992-12-31 IMMUNEX CORP /DE/ (edgar:719529) Operating Cash Flow: -3620000 USD Concept: fundies:OperatingCashFlow Period: 1992-01-01 to 1992-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529/explain?concept=fundies%3AOperatingCashFlow&period=1992-12-31&surface=latest&period_type=duration&start=1992-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3620000 USD (1992-01-01 to 1992-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0000912057-95-001512.txt#2165 The citation records this snapshot. The page link may show a newer release later.	USD 29.94 million Exact value Exact value: 29936000 USD 1992-01-01 – 1992-12-31: 29936000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IMMUNEX CORP /DE/ · 1992-12-31 IMMUNEX CORP /DE/ (edgar:719529) Capital Expenditure: 29936000 USD Concept: fundies:CapitalExpenditure Period: 1992-01-01 to 1992-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529/explain?concept=fundies%3ACapitalExpenditure&period=1992-12-31&surface=latest&period_type=duration&start=1992-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 29936000 USD (1992-01-01 to 1992-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0000912057-95-001512.txt#2168 The citation records this snapshot. The page link may show a newer release later.	−USD 33.56 million Calculation and evidence -3620000 − 29936000 USD Exact free cash flow: -33556000 USD 1992-01-01 – 1992-12-31: -3620000 USD · Inspect Operating Cash Flow · Source 1992-01-01 – 1992-12-31: 29936000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IMMUNEX CORP /DE/ · 1992-12-31 IMMUNEX CORP /DE/ (edgar:719529) Free cash flow: -33556000 USD Concept: free-cash-flow Period: 1992-01-01 to 1992-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3620000 USD (1992-01-01 to 1992-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0000912057-95-001512.txt#2165 Input fundies:CapitalExpenditure: 29936000 USD (1992-01-01 to 1992-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0000912057-95-001512.txt#2168 The citation records this snapshot. The page link may show a newer release later.
1993 1993-01-01 – 1993-12-31	−USD 366.14 million Exact value Exact value: -366135000 USD 1993-01-01 – 1993-12-31: -366135000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IMMUNEX CORP /DE/ · 1993-12-31 IMMUNEX CORP /DE/ (edgar:719529) Net Income: -366135000 USD Concept: fundies:NetIncome Period: 1993-01-01 to 1993-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529/explain?concept=fundies%3ANetIncome&period=1993-12-31&surface=latest&period_type=duration&start=1993-01-01&unit=USD&dimensions= Input fundies:NetIncome: -366135000 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0000912057-96-004613.txt#2200 The citation records this snapshot. The page link may show a newer release later.	−USD 31.27 million Exact value Exact value: -31271000 USD 1993-01-01 – 1993-12-31: -31271000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IMMUNEX CORP /DE/ · 1993-12-31 IMMUNEX CORP /DE/ (edgar:719529) Operating Cash Flow: -31271000 USD Concept: fundies:OperatingCashFlow Period: 1993-01-01 to 1993-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529/explain?concept=fundies%3AOperatingCashFlow&period=1993-12-31&surface=latest&period_type=duration&start=1993-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -31271000 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0000912057-96-004613.txt#2220 The citation records this snapshot. The page link may show a newer release later.	USD 6.12 million Exact value Exact value: 6119000 USD 1993-01-01 – 1993-12-31: 6119000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IMMUNEX CORP /DE/ · 1993-12-31 IMMUNEX CORP /DE/ (edgar:719529) Capital Expenditure: 6119000 USD Concept: fundies:CapitalExpenditure Period: 1993-01-01 to 1993-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529/explain?concept=fundies%3ACapitalExpenditure&period=1993-12-31&surface=latest&period_type=duration&start=1993-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6119000 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0000912057-96-004613.txt#2223 The citation records this snapshot. The page link may show a newer release later.	−USD 37.39 million Calculation and evidence -31271000 − 6119000 USD Exact free cash flow: -37390000 USD 1993-01-01 – 1993-12-31: -31271000 USD · Inspect Operating Cash Flow · Source 1993-01-01 – 1993-12-31: 6119000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IMMUNEX CORP /DE/ · 1993-12-31 IMMUNEX CORP /DE/ (edgar:719529) Free cash flow: -37390000 USD Concept: free-cash-flow Period: 1993-01-01 to 1993-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -31271000 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0000912057-96-004613.txt#2220 Input fundies:CapitalExpenditure: 6119000 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0000912057-96-004613.txt#2223 The citation records this snapshot. The page link may show a newer release later.
1994 1994-01-01 – 1994-12-31	−USD 33.1 million Exact value Exact value: -33104000 USD 1994-01-01 – 1994-12-31: -33104000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IMMUNEX CORP /DE/ · 1994-12-31 IMMUNEX CORP /DE/ (edgar:719529) Net Income: -33104000 USD Concept: fundies:NetIncome Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529/explain?concept=fundies%3ANetIncome&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:NetIncome: -33104000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0000912057-97-009205.txt#2512 The citation records this snapshot. The page link may show a newer release later.	−USD 15.74 million Exact value Exact value: -15735000 USD 1994-01-01 – 1994-12-31: -15735000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IMMUNEX CORP /DE/ · 1994-12-31 IMMUNEX CORP /DE/ (edgar:719529) Operating Cash Flow: -15735000 USD Concept: fundies:OperatingCashFlow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529/explain?concept=fundies%3AOperatingCashFlow&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15735000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0000912057-97-009205.txt#2524 The citation records this snapshot. The page link may show a newer release later.	USD 7.79 million Exact value Exact value: 7791000 USD 1994-01-01 – 1994-12-31: 7791000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IMMUNEX CORP /DE/ · 1994-12-31 IMMUNEX CORP /DE/ (edgar:719529) Capital Expenditure: 7791000 USD Concept: fundies:CapitalExpenditure Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529/explain?concept=fundies%3ACapitalExpenditure&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7791000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0000912057-97-009205.txt#2526 The citation records this snapshot. The page link may show a newer release later.	−USD 23.53 million Calculation and evidence -15735000 − 7791000 USD Exact free cash flow: -23526000 USD 1994-01-01 – 1994-12-31: -15735000 USD · Inspect Operating Cash Flow · Source 1994-01-01 – 1994-12-31: 7791000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IMMUNEX CORP /DE/ · 1994-12-31 IMMUNEX CORP /DE/ (edgar:719529) Free cash flow: -23526000 USD Concept: free-cash-flow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15735000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0000912057-97-009205.txt#2524 Input fundies:CapitalExpenditure: 7791000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0000912057-97-009205.txt#2526 The citation records this snapshot. The page link may show a newer release later.
1995 1995-01-01 – 1995-12-31	−USD 11.3 million Exact value Exact value: -11300000 USD 1995-01-01 – 1995-12-31: -11300000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IMMUNEX CORP /DE/ · 1995-12-31 IMMUNEX CORP /DE/ (edgar:719529) Net Income: -11300000 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11300000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001047469-98-010924.txt#2916 The citation records this snapshot. The page link may show a newer release later.	USD 11.4 million Exact value Exact value: 11398000 USD 1995-01-01 – 1995-12-31: 11398000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IMMUNEX CORP /DE/ · 1995-12-31 IMMUNEX CORP /DE/ (edgar:719529) Operating Cash Flow: 11398000 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 11398000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0000912057-97-009205.txt#2524 The citation records this snapshot. The page link may show a newer release later.	USD 5.25 million Exact value Exact value: 5246000 USD 1995-01-01 – 1995-12-31: 5246000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IMMUNEX CORP /DE/ · 1995-12-31 IMMUNEX CORP /DE/ (edgar:719529) Capital Expenditure: 5246000 USD Concept: fundies:CapitalExpenditure Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529/explain?concept=fundies%3ACapitalExpenditure&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5246000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001047469-98-010924.txt#2932 The citation records this snapshot. The page link may show a newer release later.	USD 6.15 million Calculation and evidence 11398000 − 5246000 USD Exact free cash flow: 6152000 USD 1995-01-01 – 1995-12-31: 11398000 USD · Inspect Operating Cash Flow · Source 1995-01-01 – 1995-12-31: 5246000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IMMUNEX CORP /DE/ · 1995-12-31 IMMUNEX CORP /DE/ (edgar:719529) Free cash flow: 6152000 USD Concept: free-cash-flow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 11398000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0000912057-97-009205.txt#2524 Input fundies:CapitalExpenditure: 5246000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001047469-98-010924.txt#2932 The citation records this snapshot. The page link may show a newer release later.
1996 1996-01-01 – 1996-12-31	−USD 53.63 million Exact value Exact value: -53632000 USD 1996-01-01 – 1996-12-31: -53632000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IMMUNEX CORP /DE/ · 1996-12-31 IMMUNEX CORP /DE/ (edgar:719529) Net Income: -53632000 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -53632000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001047469-99-010399.txt#3587 The citation records this snapshot. The page link may show a newer release later.	−USD 43.05 million Exact value Exact value: -43049000 USD 1996-01-01 – 1996-12-31: -43049000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IMMUNEX CORP /DE/ · 1996-12-31 IMMUNEX CORP /DE/ (edgar:719529) Operating Cash Flow: -43049000 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -43049000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0000912057-97-009205.txt#2524 The citation records this snapshot. The page link may show a newer release later.	USD 4.66 million Exact value Exact value: 4656000 USD 1996-01-01 – 1996-12-31: 4656000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IMMUNEX CORP /DE/ · 1996-12-31 IMMUNEX CORP /DE/ (edgar:719529) Capital Expenditure: 4656000 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4656000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001047469-99-010399.txt#3602 The citation records this snapshot. The page link may show a newer release later.	−USD 47.71 million Calculation and evidence -43049000 − 4656000 USD Exact free cash flow: -47705000 USD 1996-01-01 – 1996-12-31: -43049000 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 4656000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IMMUNEX CORP /DE/ · 1996-12-31 IMMUNEX CORP /DE/ (edgar:719529) Free cash flow: -47705000 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -43049000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0000912057-97-009205.txt#2524 Input fundies:CapitalExpenditure: 4656000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001047469-99-010399.txt#3602 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	−USD 15.77 million Exact value Exact value: -15772000 USD 1997-01-01 – 1997-12-31: -15772000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IMMUNEX CORP /DE/ · 1997-12-31 IMMUNEX CORP /DE/ (edgar:719529) Net Income: -15772000 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15772000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0000912057-00-010203.txt#3503 The citation records this snapshot. The page link may show a newer release later.	USD 15.06 million Exact value Exact value: 15063000 USD 1997-01-01 – 1997-12-31: 15063000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IMMUNEX CORP /DE/ · 1997-12-31 IMMUNEX CORP /DE/ (edgar:719529) Operating Cash Flow: 15063000 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 15063000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0000912057-00-010203.txt#3517 The citation records this snapshot. The page link may show a newer release later.	USD 7.41 million Exact value Exact value: 7409000 USD 1997-01-01 – 1997-12-31: 7409000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IMMUNEX CORP /DE/ · 1997-12-31 IMMUNEX CORP /DE/ (edgar:719529) Capital Expenditure: 7409000 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7409000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0000912057-00-010203.txt#3520 The citation records this snapshot. The page link may show a newer release later.	USD 7.65 million Calculation and evidence 15063000 − 7409000 USD Exact free cash flow: 7654000 USD 1997-01-01 – 1997-12-31: 15063000 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 7409000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IMMUNEX CORP /DE/ · 1997-12-31 IMMUNEX CORP /DE/ (edgar:719529) Free cash flow: 7654000 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 15063000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0000912057-00-010203.txt#3517 Input fundies:CapitalExpenditure: 7409000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0000912057-00-010203.txt#3520 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	USD 986,000 Exact value Exact value: 986000 USD 1998-01-01 – 1998-12-31: 986000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IMMUNEX CORP /DE/ · 1998-12-31 IMMUNEX CORP /DE/ (edgar:719529) Net Income: 986000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: 986000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001032210-01-000402.txt#3744 The citation records this snapshot. The page link may show a newer release later.	USD 23.23 million Exact value Exact value: 23228000 USD 1998-01-01 – 1998-12-31: 23228000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IMMUNEX CORP /DE/ · 1998-12-31 IMMUNEX CORP /DE/ (edgar:719529) Operating Cash Flow: 23228000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 23228000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001032210-01-000402.txt#3760 The citation records this snapshot. The page link may show a newer release later.	USD 29.39 million Exact value Exact value: 29389000 USD 1998-01-01 – 1998-12-31: 29389000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IMMUNEX CORP /DE/ · 1998-12-31 IMMUNEX CORP /DE/ (edgar:719529) Capital Expenditure: 29389000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 29389000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001032210-01-000402.txt#3763 The citation records this snapshot. The page link may show a newer release later.	−USD 6.16 million Calculation and evidence 23228000 − 29389000 USD Exact free cash flow: -6161000 USD 1998-01-01 – 1998-12-31: 23228000 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 29389000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IMMUNEX CORP /DE/ · 1998-12-31 IMMUNEX CORP /DE/ (edgar:719529) Free cash flow: -6161000 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 23228000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001032210-01-000402.txt#3760 Input fundies:CapitalExpenditure: 29389000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001032210-01-000402.txt#3763 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	USD 44.32 million Exact value Exact value: 44324000 USD 1999-01-01 – 1999-12-31: 44324000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IMMUNEX CORP /DE/ · 1999-12-31 IMMUNEX CORP /DE/ (edgar:719529) Net Income: 44324000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: 44324000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001032210-02-000357.txt#4374 The citation records this snapshot. The page link may show a newer release later.	USD 112.73 million Exact value Exact value: 112732000 USD 1999-01-01 – 1999-12-31: 112732000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IMMUNEX CORP /DE/ · 1999-12-31 IMMUNEX CORP /DE/ (edgar:719529) Operating Cash Flow: 112732000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 112732000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001032210-02-000357.txt#4388 The citation records this snapshot. The page link may show a newer release later.	USD 35.56 million Exact value Exact value: 35563000 USD 1999-01-01 – 1999-12-31: 35563000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IMMUNEX CORP /DE/ · 1999-12-31 IMMUNEX CORP /DE/ (edgar:719529) Capital Expenditure: 35563000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 35563000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001032210-02-000357.txt#4392 The citation records this snapshot. The page link may show a newer release later.	USD 77.17 million Calculation and evidence 112732000 − 35563000 USD Exact free cash flow: 77169000 USD 1999-01-01 – 1999-12-31: 112732000 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 35563000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IMMUNEX CORP /DE/ · 1999-12-31 IMMUNEX CORP /DE/ (edgar:719529) Free cash flow: 77169000 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 112732000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001032210-02-000357.txt#4388 Input fundies:CapitalExpenditure: 35563000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001032210-02-000357.txt#4392 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	USD 154.35 million Exact value Exact value: 154352000 USD 2000-01-01 – 2000-12-31: 154352000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IMMUNEX CORP /DE/ · 2000-12-31 IMMUNEX CORP /DE/ (edgar:719529) Net Income: 154352000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: 154352000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001032210-02-000357.txt#4374 The citation records this snapshot. The page link may show a newer release later.	USD 171.88 million Exact value Exact value: 171880000 USD 2000-01-01 – 2000-12-31: 171880000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IMMUNEX CORP /DE/ · 2000-12-31 IMMUNEX CORP /DE/ (edgar:719529) Operating Cash Flow: 171880000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 171880000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001032210-02-000357.txt#4388 The citation records this snapshot. The page link may show a newer release later.	USD 80.68 million Exact value Exact value: 80675000 USD 2000-01-01 – 2000-12-31: 80675000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IMMUNEX CORP /DE/ · 2000-12-31 IMMUNEX CORP /DE/ (edgar:719529) Capital Expenditure: 80675000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 80675000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001032210-02-000357.txt#4392 The citation records this snapshot. The page link may show a newer release later.	USD 91.21 million Calculation and evidence 171880000 − 80675000 USD Exact free cash flow: 91205000 USD 2000-01-01 – 2000-12-31: 171880000 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 80675000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IMMUNEX CORP /DE/ · 2000-12-31 IMMUNEX CORP /DE/ (edgar:719529) Free cash flow: 91205000 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 171880000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001032210-02-000357.txt#4388 Input fundies:CapitalExpenditure: 80675000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001032210-02-000357.txt#4392 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	USD 169.96 million Exact value Exact value: 169963000 USD 2001-01-01 – 2001-12-31: 169963000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IMMUNEX CORP /DE/ · 2001-12-31 IMMUNEX CORP /DE/ (edgar:719529) Net Income: 169963000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: 169963000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001032210-02-000357.txt#4374 The citation records this snapshot. The page link may show a newer release later.	USD 224.29 million Exact value Exact value: 224285000 USD 2001-01-01 – 2001-12-31: 224285000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IMMUNEX CORP /DE/ · 2001-12-31 IMMUNEX CORP /DE/ (edgar:719529) Operating Cash Flow: 224285000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 224285000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001032210-02-000357.txt#4388 The citation records this snapshot. The page link may show a newer release later.	USD 65.01 million Exact value Exact value: 65011000 USD 2001-01-01 – 2001-12-31: 65011000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IMMUNEX CORP /DE/ · 2001-12-31 IMMUNEX CORP /DE/ (edgar:719529) Capital Expenditure: 65011000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 65011000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001032210-02-000357.txt#4392 The citation records this snapshot. The page link may show a newer release later.	USD 159.27 million Calculation and evidence 224285000 − 65011000 USD Exact free cash flow: 159274000 USD 2001-01-01 – 2001-12-31: 224285000 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 65011000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IMMUNEX CORP /DE/ · 2001-12-31 IMMUNEX CORP /DE/ (edgar:719529) Free cash flow: 159274000 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T10:45:46Z Snapshot: 361a48b0152e70d661353618dd0f82e32fea8fa2d4ad8d2033cd3a2c5fcce8c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/719529?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 224285000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001032210-02-000357.txt#4388 Input fundies:CapitalExpenditure: 65011000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/719529/0001032210-02-000357.txt#4392 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

31 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000719529, 719529, edgar:719529

IMMUNEX CORP /DE/

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2001 2001-01-01 – 2001-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation